• 
  Michèle Beau-Faller, Erwan Pencreach, Charlotte Leduc, Hélène Blons, Jean-Philippe Merlio, et al.. Independent prognostic value of ultra-sensitive quantification of tumor pre-treatment T790M subclones in EGFR mutated non-small cell lung cancer (NSCLC) treated by first/second generation TKI, depends on variant allele frequency (VAF): Results of the French cooperative thoracic intergroup (IFCT) biomarkers France project. Lung Cancer, Elsevier, 2020, 140, pp.19-26. ⟨10.1016/j.lungcan.2019.10.013⟩. ⟨hal-02483277⟩
• 
  Thibault Voron, Caroline Gronnier, Arnaud Pasquer, Jérémie Thereaux, Johan Gagnière, et al.. Adenocarcinoma of the oesophagogastric junction Siewert II: An oesophageal cancer better cured with total gastrectomy. EJSO - European Journal of Surgical Oncology, WB Saunders, 2019, 45 (12), pp.2473-2481. ⟨10.1016/j.ejso.2019.07.022⟩. ⟨hal-02533008⟩
• 
  P. Gougis, M. Carton, C. Tchokothe, M. Campone, F. Dalenc, et al.. CinéBreast-factors influencing the time to first metastatic recurrence in breast cancer: Analysis of real-life data from the French ESME MBC database. The Breast, 2020, 49, pp.17-24. ⟨10.1016/j.breast.2019.10.004⟩. ⟨hal-02888468⟩
• 
  Maud Toulmonde, Marina Pulido, Isabelle Ray-Coquard, Thierry André, Nicolas Isambert, et al.. Pazopanib or methotrexate–vinblastine combination chemotherapy in adult patients with progressive desmoid tumours (DESMOPAZ): a non-comparative, randomised, open-label, multicentre, phase 2 study. The Lancet Oncology, 2019, 20 (9), pp.1263-1272. ⟨10.1016/S1470-2045(19)30276-1⟩. ⟨hal-02533355⟩
• 
  A. Le Cesne, P. Marec-Berard, J.-Y. Blay, N. Gaspar, F. Bertucci, et al.. Programmed cell death 1 (PD-1) targeting in patients with advanced osteosarcomas: results from the PEMBROSARC study. European Journal of Cancer, Elsevier, 2019, 119, pp.151-157. ⟨10.1016/j.ejca.2019.07.018⟩. ⟨hal-02529696⟩
• 
  Yohan Fayet, Christine Chevreau, Gauthier Decanter, Cécile Dalban, Pierre Méeus, et al.. No Geographical Inequalities in Survival for Sarcoma Patients in France: A Reference Networks' Outcome?. Cancers, MDPI, 2022, 14 (11), pp.2620. ⟨10.3390/cancers14112620⟩. ⟨hal-03718397⟩
• 
  Nadine Abdel Hadi, Emeline Boet, Airelle Lahalle, Laura Lauture, Alice Refeyton, et al.. Meeting report of the 4th biennial Metabolism and Cancer symposium. FEBS Journal, Wiley, 2021, ⟨10.1111/febs.16295⟩. ⟨hal-03716537⟩
• 
  Mauricette Michallet, Jean El Cheikh, Raoul Herbrecht, Ibrahim Yakoub-Agha, Denis Caillot, et al.. Systemic antifungal strategies in allogeneic hematopoietic stem cell recipients hospitalized in french hematology units: a post-hoc analysis of the cross-sectional observational AFHEM study. BMC Infectious Diseases, BioMed Central, 2022, 22 (1), pp.352. ⟨10.1186/s12879-022-07216-6⟩. ⟨inserm-03694319⟩
• 
  Jibba Amraoui, Camille Pouliquen, Julien Fraisse, Jacques Dubourdieu, Sophie Rey Dit Guzer, et al.. Effects of a Hypnosis Session Before General Anesthesia on Postoperative Outcomes in Patients Who Underwent Minor Breast Cancer Surgery. JAMA Network Open, American Medical Association, 2018, 1 (4), pp.e181164. ⟨10.1001/jamanetworkopen.2018.1164⟩. ⟨hal-02353734⟩
• 
  Marie-Pierre Buisine, Valérie Bonadona, Stephanie Baert-Desurmont, Delphine Bonnet, Florence Coulet, et al.. La polypose associée à MUTYH : synthèse et actualisation des recommandations françaises établies en 2012 sous l’égide de l’Institut national du cancer (INCa). Bulletin du Cancer, John Libbey Eurotext, 2020, 107 (5), pp.586-600. ⟨10.1016/j.bulcan.2020.02.004⟩. ⟨hal-02882284⟩
• 
  Sophie Frank, Matthieu Carton, Coraline Dubot, Mario Campone, Barbara Pistilli, et al.. Impact of age at diagnosis of metastatic breast cancer on overall survival in the real-life ESME metastatic breast cancer cohort. Breast, Elsevier, 2020, 52, pp.50-57. ⟨10.1016/j.breast.2020.04.009⟩. ⟨hal-02888009v2⟩
• 
  Maud Maillard, Christine Chevreau, Félicien Le Louedec, Manon Cassou, Caroline Delmas, et al.. Pharmacogenetic Study of Trabectedin-Induced Severe Hepatotoxicity in Patients with Advanced Soft Tissue Sarcoma. Cancers, MDPI, 2020, 12 (12), pp.3647. ⟨10.3390/cancers12123647⟩. ⟨hal-03623645⟩
• 
  Lieske Schrijver, Antonis Antoniou, Håkan Olsson, Thea Mooij, Marie-José Roos-Blom, et al.. Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study. American Journal of Obstetrics and Gynecology, Elsevier, 2021, 225 (1), pp.51.e1-51.e17. ⟨10.1016/j.ajog.2021.01.014⟩. ⟨hal-03664541⟩
• 
  Cecile Vicier, Patrick Sfumato, Nicolas Isambert, Florence Dalenc, Marie Robert, et al.. TAKTIC: A prospective, multicentre, uncontrolled, phase IB/II study of LY2780301, a p70S6K/AKT inhibitor, in combination with weekly paclitaxel in HER2-negative advanced breast cancer patients. European Journal of Cancer, Elsevier, 2021, 159, pp.205 - 214. ⟨10.1016/j.ejca.2021.09.040⟩. ⟨inserm-03647613⟩
• 
  Fabien Moinard-Butot, Caroline Saint-Martin, Carole Pflumio, Matthieu Carton, William Jacot, et al.. Efficacy of trastuzumab emtansine (T-DM1) and lapatinib after dual HER2 inhibition with trastuzumab and pertuzumab in patient with metastatic breast cancer: Retrospective data from a French multicenter real-life cohort. Breast, Elsevier, 2022, 63, pp.54-60. ⟨10.1016/j.breast.2022.03.004⟩. ⟨hal-03647242⟩
• 
  B Teste, P Rouanet, J-J Tuech, A Valverde, B Lelong, et al.. Early and late morbidity of local excision after chemoradiotherapy for rectal cancer. BJS Open, Oxford University Press, 2021, 5 (3), pp.zrab043. ⟨10.1093/bjsopen/zrab043⟩. ⟨hal-03637680⟩
• 
  Maria Katsogiannou, Jean-Baptiste Boyer, Alberto Valdeolivas, Elisabeth Remy, Laurence Calzone, et al.. Integrative proteomic and phosphoproteomic profiling of prostate cell lines. PLoS ONE, Public Library of Science, 2019, 14 (11), pp.e0224148. ⟨10.1371/journal.pone.0224148⟩. ⟨hal-03614575⟩
• 
  Leila Bengrine, Naoual Bakrin, Frédérique Rousseau, Vincent Lavoué, Claire Falandry. Multi-Disciplinary Care Planning of Ovarian Cancer in Older Patients: General Statement-A Position Paper from SOFOG-GINECO-FRANCOGYN-SFPO. Cancers, MDPI, 2022, 14 (5), pp.1295. ⟨10.3390/cancers14051295⟩. ⟨hal-03613005⟩
• 
  L. Mezquita, F. Barlesi, G. Ielsch, J. Merlio, D. Debieuvre, et al.. FP09.05 Driver Oncogenic Alterations and Indoor Radon in NSCLC Patients From the IFCT Biomarker Cohort: Bioradon France Study. Journal of Thoracic Oncology, Lippincott, Williams & Wilkins, 2021, 16 (3), pp.S214. ⟨10.1016/j.jtho.2021.01.122⟩. ⟨hal-03603784⟩
• 
  Lucille Stuani, Marie Sabatier, Estelle Saland, Guillaume Cognet, Nathalie Poupin, et al.. Mitochondrial metabolism supports resistance to IDH mutant inhibitors in acute myeloid leukemia. Journal of Experimental Medicine, Rockefeller University Press, 2021, 218 (5), pp.e20200924. ⟨10.1084/jem.20200924⟩. ⟨hal-03563454⟩

199

317